Error: Could not add to watchlist. X

CF Equities HAIG - Pharma

+ Watchlist
CFEQPHB:LX
85.40
EUR
0.06
0.07%
As of 00:59:30 ET on 07/03/2015.
Volume
0
Previous Close
85.46
52Wk Range
70.68 - 93.04
1 Yr Return
13.07%
Fund Type
-
Objective
-
Asset Class Focus
-
Geographic Focus
-
NAV (on 07/03/2015)
85.4
Total Assets (m EUR) (on 07/03/2015)
4.863
Inception Date
08/18/1999
Last Dividend (on -)
-
Dividend Indicated Gross Yield
-
Fund Managers
-
Front Load Fee
5.00%
Back Load Fee
0.00%
Redemption Fee
0.00%
12b-1 Fee
-
Current Mgmt Fee
2.00%
Expense Ratio
3.06%
Top Fund Holdings
Name Position Value % of Fund
M4E AG 172.92 k 542.97 k 10.36
Burcon NutraScience Corp 221.26 k 489.50 k 9.34
Erytech Pharma SA 9.00 k 322.56 k 6.16
SYMTEX 8 12/03/18 350.00 318.94 k 6.09
Valeant Pharmaceuticals Intern 1.00 k 221.43 k 4.23
Epigenomics AG 38.00 k 217.36 k 4.15
Eli Lilly & Co 3.00 k 209.98 k 4.01
MorphoSys AG 3.00 k 207.00 k 3.95
Formycon AG 7.00 k 206.54 k 3.94
GlaxoSmithKline PLC 10.00 k 204.54 k 3.90
Profile
CF Equities HAIG - Pharma is an open-end investment fund incorporated in Luxembourg. The Fund's objective is to achieve the highest possible growth with its invested capital. The Fund invests primarily in equities of companies within the health industry. Pharmaceuticals, Health Services, Biotech, and the production of drugs are all possible sectors to be invested in worldwide.
ADDRESS
Hauck & Aufhaeuser Inves Gesell SA
21, Avenue de la Liberte
L-1931 Luxembourg
Luxembourg
PHONE
Tel +352 45 13 14 500